OFATUMUMAB — all Canadian products
4 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is OFATUMUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02511363 | KESIMPTA | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | Subcutaneous | OFATUMUMAB 20 MG | Approved | |
| 02511355 | KESIMPTA | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | Subcutaneous | OFATUMUMAB 20 MG | Marketed | |
| 02381559 | ARZERRA | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | Intravenous | OFATUMUMAB 100 MG | Cancelled Post Market | |
| 02381567 | ARZERRA | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | Intravenous | OFATUMUMAB 1000 MG | Cancelled Post Market |
Browse other molecules: